Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Winocour

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Changes in the properties of platelets from rats with experimentally induced shortened platelet survivalP D Winocour, R L Kinlough-Rathbone, D W Perry, et al.
Thrombosis Research|January 1, 1985
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survivalM Cattaneo, P D Winocour, D A Somers, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residuesS Lévesque, Y St-Denis, B Bachand, et al.
Diabetes|February 1, 1990
Reduced membrane fluidity in platelets from diabetic patientsP D Winocour, M Bryszewska, C Watala, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Changes in the properties of platelets from rats with experimentally induced shortened platelet survivalP D Winocour, R L Kinlough-Rathbone, D W Perry, et al.
Thrombosis Research|January 1, 1985
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survivalM Cattaneo, P D Winocour, D A Somers, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residuesS Lévesque, Y St-Denis, B Bachand, et al.
Diabetes|February 1, 1990
Reduced membrane fluidity in platelets from diabetic patientsP D Winocour, M Bryszewska, C Watala, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 6